Excerpts from the NIH GUIDE- August 15, 2008 – December 10, 2008
Includes Notices and Initiatives: Requests for Applications (RFAs) and Program Announcements (PAs), published since the October 2008 Council presentation of the Director’s Status Report (DSR) to the National Advisory Council on Aging (NACA).
Also check our NIA website for Funding Opportunities.
(Shown here are selected Notices and Initiatives relevant to NIA/National Institutes of Health/DHHS).
TABLE OF CONTENTS
-
NIA & NIH INITIATIVES - Not Roadmap-related (Sections A-I)
- FUNDING OPPORTUNITIES – RFAs (NIA's)
- FUNDING OPPORTUNITIES – RFAs (NIH's)
- FUNDING OPPORTUNITIES – RFAs (Other ICs')
- FUNDING OPPORTUNITIES – PAs/PARs/PASs (NIA's)
- FUNDING OPPORTUNITIES – PAs/PARs/PASs (NIH's)
- FUNDING OPPORTUNITIES – PAs/PARs/PASs (Other IC's)
- NOTICES ISSUED BY NIA
- NOTICES ISSUED BY NIH
- NOTICES ISSUED BY OTHER ICs – Notices issued by Other ICs with NIA involvement.
- NIH NOTICES & INITIATIVES - Roadmap-related (Sections J-L)
NIA & NIH INITIATIVES - Not Roadmap-related (Sections A-I)
|
A. FUNDING OPPORTUNITIES – RFAs (NIA's ) - those issued by NIA as the primary IC. (Announcements are sorted by release date. Most recent announcements are at the top of this list.) |
|||||||
| # | Announcement Number | Issuing Organization | Release Date | Opening Date |
Expiration Date |
Activity Code(s) | Title |
|---|---|---|---|---|---|---|---|
|
1 |
NIA |
12/03/2008 |
02/10/2009 |
03/11/2009 |
R01 |
Partnering Awards to Support Collaborative Research on the Biology of Aging (R01) |
|
|
Purpose - The purpose of this initiative is to solicit three year Research Project Grant (R01) applications from research partners in the United States (U.S.) and the United Kingdom (U.K.) to support collaborative research projects focused on understanding the biology of aging. Scientific/Research Contact: |
|||||||
|
2 |
NIA |
11/13/2008 |
01/16/2009 |
01/17/2009 |
U01 |
Limited Competition: Renewal of Aging Intervention Testing Program (U01) |
|
|
Purpose – The purpose of this initiative is to continue the Aging Intervention Testing Program (ITP) cooperative agreement program. The ITP was designed to test, under standardized conditions at multiple sites, putative interventions with potential to extend lifespan and health span in a mammalian model. Scientific/Research Contact: |
|||||||
|
B. FUNDING OPPORTUNITIES –RFAs (NIH's) Not Roadmap-related-those issued by NIH that are not Roadmap-related, in which NIA is involved. |
|
C. FUNDING OPPORTUNITIES – RFAs (NIH's )–issued by Other ICs with NIA involvement. (Announcements are sorted by release date. Most recent announcements are at the top of this list.) |
|||||||
| # |
Announcement Number |
Issuing Organization | Release Date | Opening Date | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|---|---|---|
|
1 |
NIGMS |
08/15/2008 |
09/29/2008 |
10/29/2008 |
R01 |
Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) (R01) |
|
|
Purpose - applications from institutions/organizations proposing exceptionally innovative research on novel hypotheses or difficult problems, solutions to which would have an extremely high impact on biomedical or biobehavioral research that is germane to the mission of one or more of the participating NIH Institutes. Scientific/Research Contact: Robin Barr, Ph.D.Office of Extramural Activities National Institute on Aging Gateway Building, Room 2C218 7201 Wisconsin Avenue, MSC 9205 Bethesda, MD 20892-9205 (use Bethesda, MD 20814 for express mailing) Telephone: (301) 496-9322 Fax: (301) 402-2945 Email: BarrR@nia.nih.gov |
|||||||
|
D. FUNDING OPPORTUNITIES – PAs/PARs/PASs (NIA's). (Announcements are sorted by release date. Most recent announcements are at the top of this list.) |
|||||||
| # |
Announcement Number |
Issuing Organization | Release Date | Opening Date | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|---|---|---|
|
1 |
NIA |
10/29/2008 |
12/07/2008 |
01/08/2012 |
R01, R03, |
Medical Management of Older Patients with HIV/AIDS |
|
|
Purpose - The purpose of this initiative is to encourages Small Research Grant (R03) applications that address clinical and translational medical issues in the diagnosis and/or management of HIV infection and its consequences in older persons. Scientific/Research Contact: |
|||||||
|
2 |
NIA |
09/18/2008 |
02/02/2009 |
01/08/2012 |
U01 |
Alzheimer’s Disease Drug Development Program (U01) |
|
|
Purpose - The purpose of this initiative is to stimulate research in the pre-clinical development and testing of novel therapeutic compounds aimed at slowing, halting, or reversing the progressive decline in cognitive function and modifying the behavioral symptoms in Alzheimer's disease (AD); or delaying the onset of or preventing AD, mild cognitive impairment (MCI), or age-related cognitive decline. Scientific/Research Contact: |
|||||||
|
3 |
NIA |
08/25/2008 |
09/16/2008 |
09/08/2010 |
R03 |
Archiving and Development of Socialbehavioral Datasets in Aging Related Studies (R03) |
|
|
Purpose - The purpose of this initiative is to encourage small grant (R03) applications to stimulate and facilitate data archiving and development related to cognitive psychology, behavioral interventions in the context of randomized controlled trials (RCTs), demography, economics, epidemiology, behavioral genetics and other behavioral research on aging for secondary analysis. Scientific/Research Contact: |
|||||||
|
4 |
NIA |
08/25/2008 |
09/16/2008 |
01/08/2011 |
R36 |
Aging Research Dissertation Awards to Increase Diversity (R36) |
|
|
Purpose - The purpose of this initiative is to provide dissertation awards (R36) in all areas of research within NIA’s mandate to increase diversity of the research workforce on research on aging and aging-related health conditions. Scientific/Research Contact: |
|||||||
|
E. FUNDING OPPORTUNITIES – PAs/PARs/PASs (NIH's) Not Roadmap-related. |
|
F. FUNDING OPPORTUNITIES – PAs/PARs/PASs (Other IC's ). |
|||||||
| # |
Announcement Number |
Issuing Organization | Release Date | Opening Date | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|---|---|---|
|
1 |
NINDS |
12/10/2008 |
01/05/2009 |
01/08/2012 |
R01, R21 |
Research on the Cognitive Sequelae of Parkinson’s Disease |
|
|
Purpose - The purpose of this initiative is to encourage applications that address the underlying neurobiological mechanisms associated with cognitive impairment and mood disturbance in Parkinson's disease (PD), that address the development of clinical interventions and therapeutics for cognitive impairment and affective symptoms in PD, or that promote improved clinical diagnosis or treatment of cognitive and affective impairment in PD Scientific/Research Contact: |
|||||||
|
2 |
NIBIB |
11/18/2008 |
12/22/2008 |
09/22/2011 |
R01 |
Innovation in Molecular Imaging Probes (R01) |
|
|
Purpose - The purpose of this initiative is to encourage the development of novel molecular imaging approaches that can detect and image specific molecular activities in vivo, and have the potential for clinical applications Scientific/Research Contact: |
|||||||
|
3 |
NIGMS |
10/06/2008 |
12/25/2008 |
01/08/2012 |
R25 |
Short Courses on Mathematical, Statistical, and Computational Tools for Studying Biological Systems (R25) |
|
|
Purpose - The purpose of this initiative is to encourage applications for Research Education Grants (R25) from institutions and organizations to conduct workshops and short courses to improve integration of mathematical, statistical, and computational approaches into biological and/or behavioral research. Scientific/Research Contact: |
|||||||
|
4 |
ORWH |
08/21/2008 |
09/05/2008 |
09/08/2011 |
R01, R21 |
Chronic Fatigue Syndrome: Pathophysiology and Treatment (R01) |
|
|
Purpose - The purpose of this initiative is to encourage investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME/CFS) in diverse groups and across the lifespan. Innovative applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, and the common mechanisms influencing the multiple body systems that are affected in CFS are encouraged. Scientific/Research Contact: |
|||||||
|
I. NOTICES ISSUED BY OTHER ICs with NIA involvement- (No Notices in this category during this time period were published.) |
